medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2009, Number 09

<< Back Next >>

Ginecol Obstet Mex 2009; 77 (09)

Clinical practice guidelines. Diagnostic and treatment of dysfunctional utherine

Ibarra CV, Lira PJ
Full text How to cite this article

Language: Spanish
References: 23
Page: 231-251
PDF size: 316.62 Kb.


Key words:

No keywords

Text Extraction

No abstract.


REFERENCES

  1. Casablanca Y. Management of dysfunctional uterine bleeding. Obstet Gynecol Clin North Am 2008;35:219-34.

  2. Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility. 6th ed. Baltimore, MD: Lippincot Williams & Wilkins; 2004 p.547-72.

  3. Society of Obstetrician and Gynaecologists of Canada. SOGC Clinical Practice Guidelines, Clinical practice gynaecology and the reproductive endocrinology infertility committee, number l, August 2001: guidelines for the management of abnormal uterine bleeding.

  4. American College of Obstetricians and Gynecologists. ACOG practice bulletin, Clinical management guidelines for obstetrician-gynecologists. number 14, March 2000: management of anovulatory bleeding.

  5. Olaiz FG, Rivera OJ, Shamah LT, Rojas R, Villalpando HS, Hernández AM, Sepúlveda AJ. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Publica; 2006.

  6. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.

  7. Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril 2004;82:S33-39.

  8. American College of Obstetricians and Gynecologists. ACOG practice bulletin, Clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 2005;106:413-25.

  9. Guido RS, Kanbour-Shakir A, Rulin MC, Christopherson WA. Pipelle endometrial sampling sensitivity in the detection of endometrial cancer. J Reprod Med 1995;33:76-78.

  10. Dijkhuizen Fp, Mol BW, Brolmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 2000;15:89:1765-72.

  11. Goldstein SR. Abnormal uterine bleeding: the role of ultrasound. Radiol Clin North Am 2006;44:901-10.

  12. Batzer FA. Abnormal uterine bleeding: imaging techniques for evaluation of the uterine cavity and endometrium befote minimally invasive surgery-the case for transvaginal ultrasonography. J Minim Invasive Gynecol 2007;14:9-11.

  13. Kelekci S, Kaya E, Alan M, Alan Y, Bilge U, Mollamahmutoglu I. Comparison of transvaginal sonography, saline infusion sonography, and office hysteroscopy in reproductive-aged women with or without abnormal uterine bleeding. Fertil Steril 2005;84:682-6.

  14. HOD Critchley, P Warner, AJ Lee, S Brechin, J Guise and B Graham. Evaluation of abnormal uterine bleeding: comparison of three outpatient procedures within cohorts defined by age and menopausal status. Evaluation of abnormal uterine bleeding: comparison of three outpatient procedures within cohorts defined by age and menopausal status. Health Technol Assess 2004;8(34).

  15. (Finnish Médical Society Duodecim. Gynaecological ultrasound examination. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2005 May 4 [Various]. avaible in: http//www.guideline.gov/summary/summary. aspx?doc_id=8239&nbr=004597&string=abnormal+AND+uterine+AND+bleeding).

  16. Amann M, Anguino H, Bauman RA, Cheung ML, Harris S, Kennedy J, Kivnick S, Lim A, Moore O, Munro M, Musoke L, Solh S. Chronic abnormal uterine bleeding in nongravid women. Pasadena (CA): Kaiser Permanente Southern California; 2006 Dec 91 p. [344 references]. avaible in: http//www.guideline.gov/summary/summary.aspx?doc_id= lo889&nbr=005687&s tring=abnormal+AND+ uterine+AND + bleeding).

  17. Iyer V, Farquhar C, Jepson R. Oral contraceptive pills for heavy menstrual bleeding. Cochrane Database Syst Rev, 2008;(2)CD000154.

  18. Lethaby A, Augood C, Duckitt K, Farquhar C Nonesteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2007 Oct 17;(4)CD000400. (Nivel de evidencia la, Grado de recomendación C).

  19. Lethaby A, Irvine G, Cameron I. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 2008 Jan 23;(1):CD001016.

  20. Lethaby AE, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002126 (Nivel de evidencia la, Grado de recomendación C).

  21. Need JA, Forbes KL, Milazzo L,McKenzie E. Danazol in the treatment of menorrhagia: the effect of a 1 month induction dose (200 mg) and 2month’s maintenance therapy (200 mg, lo0 mg, 50 mg or placebo). Aust NZ J Obstet Gynecol 11992;32:346-52.

  22. Beaumont H, Augood C, Duckitt K, Lethaby A. Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev 2007;18(3):CD001017.

  23. Marjoribanks J, Lethaby A, Farquhar C. Surgery versus médical therapy for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2006, Issue 2 Art. No.:CD003855 001:10.1002/14651858.CD003855:pub2.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2009;77